Risk factors for early seizure after revascularization in patients with moyamoya disease

被引：1
作者：
Niu H. [1 ]
Tan C. [1 ]
Jin K. [2 ]
Duan R. [1 ]
Shi G. [1 ]
Wang R. [1 ]
机构：
[1] Department of Neurosurgery, Peking University International Hospital, Beijing
[2] Department of Neurology, Peking University International Hospital, Beijing
来源：
Chinese Neurosurgical Journal | / 8卷 / 1期
关键词：
Moyamoya disease; Revascularization; Seizure;
D O I：
10.1186/s41016-022-00305-0
中图分类号：
学科分类号：
摘要：
Background: To investigate the risk factors for early seizure after revascularization in patients with moyamoya disease (MMD). Methods: A total of 298 patients with MMD diagnosed in our hospital from 2015 to 2018 were analyzed retrospectively. We summarized the characteristics of seizure after revascularization in patients with MMD and analyzed the predictors of early postoperative seizure. Results: We identified 15 patients with MMD who developed seizures within 1 week after revascularization. According to logistic regression analysis, age (OR: 1.04, 95% CI 0.998–1.086; P = 0.060) and infarct side (OR: 1.92, 95% CI 0.856–4.290; P = 0.113) were not significantly associated with incident early seizure. Postoperative infarction (OR: 12.89, 95% CI 4.198–39.525; P = 0.000) and preoperative cerebral infarction (OR: 4.08, 95% CI 1.267–13.119; P = 0.018) were confirmed as risk factors for early seizure. Conclusions: We believe that a history of preoperative infarction and new infarction are independent risk factors of early seizure in patients with MMD after revascularization. © 2022, The Author(s).
引用
收藏
相关论文
共 26 条
[1]  
Suzuki J., Takaku A., Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain, Arch Neurol., 20, 3, pp. 288-299, (1969)
[2]  
Morimoto M., Iwama T., NHAKKH, Efficacy of direct revascularization in adult moyamoya disease: haemodynamic evaluation by positron emission tomography, Acta Neurochir (Wien), 141, pp. 377-384, (1999)
[3]  
De Reuck J., Goethals M., Vonck K., Van Maele G., Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease, Eur Neurol., 54, 2, pp. 68-72, (2005)
[4]  
Hayashi K., Horie N., Suyama K., Nagata I., Clinical features and long-term follow-up of quasi-moyamoya disease in children, Pediatr Neurosurg., 47, 1, pp. 15-21, (2011)
[5]  
Morais N.M.M., Ranzan J., Riesgo R.S., Predictors of epilepsy in children with cerebrovascular disease, J Child Neurol, 28, 11, pp. 1387-1391, (2012)
[6]  
Gibson L.M., Hanby M.F., Al-Bachari S.M., Parkes L.M., Allan S.M., Emsley H.C., Late-onset epilepsy and occult cerebrovascular disease, J Cereb Blood Flow Metab., 34, 4, pp. 564-570, (2014)
[7]  
Hirano T., Enatsu R., Iihoshi S., Mikami T., Honma T., Ohnishi H., Mikuni N., Effects of hemosiderosis on epilepsy following subarachnoid hemorrhage, Neurol Med Chir (Tokyo)., 59, 1, pp. 27-32, (2019)
[8]  
Jennett W.B., Early traumatic epilepsy. Definition and identity, Lancet, 1, 7604, pp. 1023-1025, (1969)
[9]  
Guidelines for epidemiologic studies on epilepsy, Epilepsia., 34, 4, pp. 592-596, (1993)
[10]  
Hoshino H., Izawa Y., Suzuki N., Diseas RCoM. Epidemiological features of moyamoya disease in Japan, Neurol Med Chir (Tokyo), 52, pp. 295-298, (2012)
123